Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Losing both ERBB2 and ERBB3 receptors in mice causes significant skin problems and inflammation.

JAM-A modification speeds up skin wound healing by boosting fibroblast growth.

IL-18 signaling helps mature Tregs move into the thymus.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

TGase 3 helps build hair structure by forming strong bonds between proteins.

Ruxolitinib can help regrow hair in severe alopecia areata.

SIG-1451 could be a promising new treatment for atopic dermatitis.

A mother and daughter had severe skin, hair, and eye issues linked to IFAP.

Long-term opioid use can cause a serious condition where the adrenal glands don't work properly, which doctors should watch out for.

KIF18B is important for correctly positioning cell division machinery in skin cells, affecting hair follicle development.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

A group has developed therapies that show promise for treating cancer and various other conditions.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Early diagnosis and treatment of myositis in SLE patients lead to positive outcomes.

Prednisolone and Bactrim improved symptoms in a woman with Cronkhite-Canada syndrome.

Baricitinib helps patients with severe alopecia areata regrow hair.

Recognizing unusual symptoms in Crohn's disease is crucial for proper treatment.

RIPK1 inhibitors might help prevent alopecia areata.

Liposomal IGF-1 safely and effectively treats hair loss in hamsters.